about
Adverse events in patients taking macrolide antibiotics versus placebo for any indicationEvidence and evidence gaps in therapies of nasal obstruction and rhinosinusitis.Microbiomes in respiratory health and disease: An Asia-Pacific perspective.eComment. Benefits of macrolide usage and bacteriological profile in patients with diffuse panbronchiolitis[Pseudomonas aeruginosa infections in chronic obstructive pulmonary disease : Role of long-term antibiotic treatment].Autoinflammatory Disease in the Lung.
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Macrolides for diffuse panbronchiolitis
@ast
Macrolides for diffuse panbronchiolitis
@en
Macrolides for diffuse panbronchiolitis
@en-gb
Macrolides for diffuse panbronchiolitis
@nl
type
label
Macrolides for diffuse panbronchiolitis
@ast
Macrolides for diffuse panbronchiolitis
@en
Macrolides for diffuse panbronchiolitis
@en-gb
Macrolides for diffuse panbronchiolitis
@nl
prefLabel
Macrolides for diffuse panbronchiolitis
@ast
Macrolides for diffuse panbronchiolitis
@en
Macrolides for diffuse panbronchiolitis
@en-gb
Macrolides for diffuse panbronchiolitis
@nl
P2093
P2860
P1476
Macrolides for diffuse panbronchiolitis
@en
P2093
P2860
P304
P356
10.1002/14651858.CD007716.PUB4
P50
P577
2015-01-25T00:00:00Z